Cargando…
Different Pathways Mediate Amphotericin-Lactoferrin Drug Synergy in Cryptococcus and Saccharomyces
Fungal infections are an increasing cause of morbidity and mortality. Current antifungal drugs are limited in spectrum, few new drugs are in development, and resistance is an increasing issue. Drug synergy can enhance available drugs and extend their lifetime, however, few synergistic combinations a...
Autores principales: | Lai, Yu-Wen, Pang, Chi Nam Ignatius, Campbell, Leona T., Chen, Sharon C. A., Wilkins, Marc R., Carter, Dee A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779777/ https://www.ncbi.nlm.nih.gov/pubmed/31632362 http://dx.doi.org/10.3389/fmicb.2019.02195 |
Ejemplares similares
-
Transcriptome and network analyses in Saccharomyces cerevisiae reveal that amphotericin B and lactoferrin synergy disrupt metal homeostasis and stress response
por: Pang, Chi Nam Ignatius, et al.
Publicado: (2017) -
The Antifungal Activity of Lactoferrin and Its Derived Peptides: Mechanisms of Action and Synergy with Drugs against Fungal Pathogens
por: Fernandes, Kenya E., et al.
Publicado: (2017) -
Lactoferrin Is Broadly Active against Yeasts and Highly Synergistic with Amphotericin B
por: Fernandes, Kenya E., et al.
Publicado: (2020) -
Enhancement of Antimycotic Activity of Amphotericin B by Targeting the Oxidative Stress Response of Candida and Cryptococcus with Natural Dihydroxybenzaldehydes
por: Kim, Jong H., et al.
Publicado: (2012) -
S3.4b Lactoferrin, a natural source of peptides that potentiate the antifungal activity of amphotericin B
por: Fernandes, Kenya, et al.
Publicado: (2022)